These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2219318)

  • 1. A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results.
    Kelly JJ; Walker RG; d'Apice AJ; Kincaid-Smith P
    Transplant Proc; 1990 Oct; 22(5):2127-8. PubMed ID: 2219318
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of diltiazem in the prevention of acute tubular necrosis, acute rejection, and cyclosporine levels.
    Alcaraz A; Oppenheimer F; Talbot-Wright R; Fernández-Cruz L; Mañalich M; García-Pagés E; Cetina A; Vendrell JR; Carretero P
    Transplant Proc; 1991 Oct; 23(5):2383-4. PubMed ID: 1926395
    [No Abstract]   [Full Text] [Related]  

  • 3. The long-term deleterious effect of delayed graft function in cyclosporine-treated renal allograft recipients.
    Rocher LL; Landis C; Dafoe DC; Keyserling C; Swartz RD; Campbell DA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2093-5. PubMed ID: 3274476
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM; Murie JA; Allen R; Jaskowski A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract]   [Full Text] [Related]  

  • 5. Co-administration of diltiazem and cyclosporine for kidney transplant recipients: a four year follow-up study.
    Ingsathit A; Sumethkul V; Chalermsanyakorn P; Jirasiritham S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S235-41. PubMed ID: 17044477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group.
    MacDonald AS; Daloze P; Dandavino R; Jindal S; Bear L; Dossetor JB; Klassen J; Stiller CR; Lockwood B; Reeve CE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1865-6. PubMed ID: 3079054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid withdrawal with substitution of azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W; Venkat KK; Florence-Green D; Norris C; Oh HK; Dienst S; Levin NW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2024-6. PubMed ID: 3274465
    [No Abstract]   [Full Text] [Related]  

  • 8. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E; Robinson C; Bear R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
    Woodle ES; Thistlethwaite JR; Gordon JH
    Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract]   [Full Text] [Related]  

  • 11. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
    Lloveras J; Masramon J; Orfila A; Cuevas X; Aubia J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2027-8. PubMed ID: 2978888
    [No Abstract]   [Full Text] [Related]  

  • 12. Delayed graft function of cadaveric renal transplants is prevented by diltiazem.
    Carmellini M; Salvadori M; Di Stefano R; Bertoni E; Nicita G; Rosati A; Taddei G; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1996 Feb; 28(1):80-2. PubMed ID: 8644348
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute rejection under triple immunosuppressive therapy does not increase the risk of late first cadaveric renal allograft loss.
    Isoniemi H; Kyllönen L; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Ahonen J
    Transplant Proc; 1995 Feb; 27(1):875-7. PubMed ID: 7879216
    [No Abstract]   [Full Text] [Related]  

  • 14. Value of cyclosporine measurements in renal transplant recipients immunosuppressed with triple therapy.
    Taube D; Marsden J; Palmer A; Cairns T; Johnston A; Holt DW
    Transplant Proc; 1990 Jun; 22(3):1251-2. PubMed ID: 2349686
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract]   [Full Text] [Related]  

  • 16. Alternative immunosuppressive strategies in the management of recipients of living related renal transplants.
    Hodge E; Banowsky L; Novick A; Lewis R; Streem S; Steinmuller D; Holzmann J; McFarlin L; Graneto D; Medendorp SV
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1609-14. PubMed ID: 2652524
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of delayed graft function by diltiazem and iloprost.
    Neumayer HH; Schreiber M; Wagner K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1221-4. PubMed ID: 2469225
    [No Abstract]   [Full Text] [Related]  

  • 19. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal of methylprednisolone at the sixth month in renal transplant recipients treated with cyclosporine.
    Cristinelli L; Brunori G; Setti G; Manganoni A; Manganoni AM; Scolari F; Sandrini S; Scaini PS; Savoldi S; Camerini C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2021-3. PubMed ID: 3079069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.